Vanguard Capital Management
IMA

Vanguard Capital Management’s ImageneBio Inc IMA Stock Holding History

Vanguard Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
320,518
-4,637
-1% -$26.2K ﹤0.01% 3443
2026
Q1 		$1.63M Buy
+325,155
New +$2.11M ﹤0.01% 3431

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management's IMA Position: Q2 2026 in Review

Vanguard Capital Management reduced its ImageneBio Inc (IMA) stake by 1.4% in Q2 2026, selling an estimated $26.2K and leaving 320,518 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Vanguard Capital Management first reported a position in IMA in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Vanguard Capital Management held 320,518 shares of ImageneBio Inc worth $1.89M as of Q2 2026.
  • Vanguard Capital Management sold 4,637 ImageneBio Inc shares in Q2 2026, an estimated $26.2K.
  • ImageneBio Inc made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3443 holding.
  • Vanguard Capital Management first reported a position in ImageneBio Inc in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.